The association between objective CT measures of bronchiectasis and health-related quality of life in COPD

A. Diaz, J. Ross, G. Washko, R. San Jose Estepar (Boston, United States Of America)

Source: International Congress 2014 – Monitoring COPD with different biomarkers
Session: Monitoring COPD with different biomarkers
Session type: Oral Presentation
Number: 207
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Diaz, J. Ross, G. Washko, R. San Jose Estepar (Boston, United States Of America). The association between objective CT measures of bronchiectasis and health-related quality of life in COPD. Eur Respir J 2014; 44: Suppl. 58, 207

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessment of quality of life of bronchiectasis patients associated with asthma and COPD.
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019




The pulmonary artery-aorta ratio, exacerbation rate and quality of life in stable COPD patients
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014

Clinical differences between emphysematous and non-emphysematous COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Predictive role of mMRC scale on quality of life in COPD patients
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013


Quality of life in obstructive lung diseases
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013

Health-related quality of life in emphysema due to alpha-1-antitrypsin deficiency
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013



The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014


Discordant symptom severity in COPD: The PHAROAH study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Assessment of quality of life in patients with bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


COPD assessment test (CAT): Validity and reproducibility in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Physiotherapy assessment and techniques in pulmonary and non-pulmonary conditions
Year: 2015


Bronchial hyperresponsiveness as a predictor of treatment-response in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Impact of obesity on markers of asthma severity, control, health-related quality of life (HrQOL) and eosinophilia
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013


Which are the main determinants of quality-of-life in severe asthma?
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Responsiveness of the clinical COPD questionaire to pulmonary rehabilitation
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Concordance between airway inflammation and health status in COPD patients with bacterial colonisation
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


Reduction in clinically important deterioration in COPD with aclidinium/formoterol
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Cough is an independent contributor to health-related quality of life impairment in COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015

The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014